PR Newswire Asia's news > Biotechnology

< Previous page

All Airlines/Aviation Auto Maritime/Shipbuilding Transportation Computer Hardware Computer Networks Computer Software Computer/Electronics Electronic Commerce Electronic Components High Tech Security Internet Technology Peripherals Semiconductors Electronics Gaming Consumer Electronics Mobile Entertainment Multimedia/Online/Internet Telecommunications Household/Consumer/Cosmetics Retail Supermarkets Toys Alternative Energies Chemical Mining/Metals Oil/Energy Environmental Products & Services Green Technology Art Cosmetics & Personal Care Entertainment Fashion Film & Motion Picture Jewelry Banking/Financial Service Insurance Workforce Management/Human Resources Education Higher Education Biotechnology Health Care/Hospital Infectious Disease Control Medical Equipment Medical/Pharmaceuticals Agriculture Machinery Paper/Forest Products/Containers Textiles Domestic policy Legal issues Sports Hotels and Resorts Leisure/Travel/Hotels Travel Restaurants Beer, Wine & Spirits Beverages Non-Alcoholic Beverages Food/Beverages Advertising Books Music Publishing/Information Service Television Trade show news Real Estate Construction/Building Furniture & Furnishings  |   Title only   |   Print

Next page >

88IV - PR Newswire Asia's news - Biotechnology 5 Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer European Hematology Association (EHA) oral presentation to report 67% hematological improvement, durable transfusion independence, and no treatment-related serious adverse events in ESA-refractory lower-risk ... 2026-05-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of RNA Interference and Oligonucleotide Therapeutics Development SHANGHAI , May 12, 2026 /PRNewswire/ -- Insilico Medicine ( " Insilico " , 03696.HK), a biotechnology company powered by generative artificial intelligence , today announced that the company ... 2026-05-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI SUZHOU, China , May 12, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico ... 2026-05-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Avance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership The company is recognized for its innovation, scientific expertise, and customer-centric clinical development model in the global biotechnology CRO market ... 2026-05-12T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals  New Data Show Gaps in Antiviral Pipeline Against High-Risk Viral Threats Longitudinal analysis reveals clear gaps in global preparedness against emerging viral threats and future pandemics. ... 2026-05-12T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals  DNA 'barcodes' help NUS researchers pinpoint gold nanoparticles that can strike cancer at its power source A new high-throughput platform screens dozens of nanoparticle designs in living systems to identify those that reach tumour mitochondria, enabling more precise and effective cancer therapies ... 2026-05-12T    Biotechnology   Education   Health Care/Hospital   Higher Education  Ranok Therapeutics Announces the Publication of Positive Phase 1a Clinical Results for KRAS G12D Inhibitor RNK08954 in Cancer Discovery BOSTON and HANGZHOU, China , May 11, 2026 /PRNewswire/ -- Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced the publication of preliminary ... 2026-05-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Leads Biolabs R&D Symposium: Platform Synergy and Multi-Mechanism Integration Reshape the Immuno-Oncology Landscape NANJING, China , May 11, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs"; Stock Code: 9887.HK) successfully held its R&D Symposium in Shanghai. Under the theme "Leads ... 2026-05-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D TOKYO , May 11, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical ... 2026-05-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D SEOUL, South Korea , May 11, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global ... 2026-05-11T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals
< Previous page	Next page >